Valneva SE (VALN) Long-Term Investments (2020 - 2022)
Valneva SE (VALN) posted quarterly Long-Term Investments of $2.4 million for Q1 2022, little changed on a QoQ basis from $2.4 million in Q4 2021.
Valneva SE (VALN) Long-Term Investments (2020 - 2022) Analysis & Trends
Valneva SE (VALN) has reported Long-Term Investments for 3 consecutive years, with $2.4 million the latest figure, recorded in Q1 2022.
- Quarterly Long-Term Investments changed N/A year-over-year to $2.4 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $2.4 million (changed N/A YoY) and the FY2021 annual result came in at $2.4 million, changed 0.28% from the prior year.
- Long-Term Investments was little changed at $2.4 million in Q1 2022 per VALN's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Long-Term Investments for VALN reached as high as $2.4 million in Q4 2020 and fell as low as $2.4 million in Q4 2021.
- A 3-year average of $2.4 million and a median of $2.4 million in 2021 frame the typical range for Long-Term Investments.
- The largest YoY upside for Long-Term Investments was 0.28% in 2021 against a maximum downside of 0.28% in 2021.
- Year by year, Long-Term Investments stood at $2.4 million in 2020, then declined by 0.28% to $2.4 million in 2021, then changed by 0.0% to $2.4 million in 2022.
- According to Business Quant data, Long-Term Investments over the past three periods registered $2.4 million, $2.4 million, and $2.4 million for Q1 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Dec 31, 2020 | 2.42 Mn |